# ROMIDEPSIN
> **NDA208574** · New Drug Application · Sponsor: TEVA PHARMS USA INC · Approved 2020-03-13
## Drug
- **FDA Application Number:** NDA208574
- **Application type:** New Drug Application
- **Brand name:** ROMIDEPSIN
- **Generic name:** Romidepsin
- **Active ingredients:** ROMIDEPSIN
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PHARMS USA INC
- **First approval:** 2020-03-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208574)
---
*AI Analytics · CC0 1.0*